Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial

Clinical trial NCT04756505 · WITHDRAWN

Trial details

NCT number: NCT04756505
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Hormone Receptor Positive Breast Adenocarcinoma Metastatic Breast Carcinoma Metastatic HER2 Negative Breast Adenocarcinoma Prognostic Stage IV Breast Cancer AJCC v8

Start date: 2021-03-07
Primary completion: 2022-02-16
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.